Multidisciplinary management of soft-tissue sarcomas

Cancer Investigation

Volumn 20, Issue 5-6, 2002, Pages 818-824

  Maki, Robert G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; CISPLATIN; DACARBAZINE; DOXORUBICIN; ENDOSTATIN; IFOSFAMIDE; IMATINIB; MITOMYCIN; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR VACCINE; VASCULOTROPIN INHIBITOR;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; HUMAN; META ANALYSIS; METASTASIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOFT TISSUE SARCOMA; ADJUVANT CHEMOTHERAPY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; SARCOMA; SOFT TISSUE TUMOR;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING; PROGNOSIS; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0036051655     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120003547     Document Type: Review

References (24)

1. Greenlee, R.T.; Hill-Harmon, M.B.; Murray, T.; Thun, M. Cancer Statistics. CA Cancer J. Clin. 2001, 51, 15-37.
2. Ariel, I.M. Incidence of Metastases to Lymph Nodes from Soft-Tissue Sarcomas. Semin. Surg. Oncol. 1988, 4, 27-29.
3. Fleming, I.D.; Cooper, J.S.; Henson, D.E.; Hutter, R.V.P.; Kennedy, B.J. ; Murphy, G.P.; O'Sullivan, B.; Sobin, L.H.; Yarbro, J.W. AJCC Cancer Staging Manual, 5th Ed.; Lippincott-Raven: Philadelphia, 1997.
4. Brennan, M.F.; Alektiar, K.M.; Maki, R.G. Soft Tissue Sarcoma. In Cancer: Principles and Practice of Oncology, 6th Ed.; Devita, V., Jr.; Hellman, S., Rosengerg, S., Eds.; Lippincott, Williams, and Wilkins: Philadelphia, 2001; 1841-1891.
5. Yang, J.C.; Chang, A.E.; Baker, A.R.; Sindelar, W.F.; Danforth, D.N.; Topalian, S.L.; DeLaney, T.; Glatstein, E.; Steinberg, S.M.; Merino, M.J.; Rosenberg, S.A. Randomized Prospective Study of the Benefit of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcomas of the Extremity. J. Clin. Oncol. 1998, 16, 197-203.
6. Pisters, P.W.; Harrison, L.B.; Leung, D.H.; Woodruff, J.M.; Casper, E.S. ; Brennan, M.F. Long-Term Results of a Prospective Randomized Trial of Adjuvant Brachytherapy in Soft Tissue Sarcoma. J. Clin. Oncol. 1996, 14, 859-868.
7. O'Sullivan, B.; Davis, A.; Bell, R.; Catton, C.; Turcotte, R.; Wunder, J.; Chabot, P.; Hammond, A.; Benk, V.; Isler, M.; Freeman, C.; Goddard, K.; Kandel, R.; Sadura, A.; James, K.; Zee, B. Phase III Randomized Trial of Pre-operative Versus Post-operative Radiotherapy in the Curative Management of Extremity Soft Tissue Sarcoma. A Canadian Sarcoma Group and NCI Canada Clinical Trials Group Study. Proc. ASCO 1999, 18, Abstract 2066.
8. Geer, R.J.; Woodruff, J.; Casper, E.S.; Brennan, M.F. Management of Small Soft-Tissue Sarcoma of the Extremity in Adults. Arch. Surg. 1992, 127, 1285-1289.
9. Fleming, J.B.; Berman, R.S.; Cheng, S.C.; Chen, N.P.; Hunt, K.K.; Feig, B.W.; Respondek, P.M.; Yasko, A.W.; Pollack, A.; Patel, S.R.; Burgess, M.A.; Papadopoulos, N.E.; Plager, C.; Zagars, G.; Benjamin, R.S.; Pollock, R.E.; Pisters, P.W. Long-term Outcome of Patients with American Joint Committee on Cancer Stage IIB Extremity Soft Tissue Sarcomas. J. Clin. Oncol. 1999, 17, 2772-2780.
10. Pirzkall, A.; Carol, M.; Lohr, F.; Hoss, A.; Wannenmacher, M.; Debus, J. Comparison of Intensity-Modulated Radiotherapy with Conventional Conformal Radiotherapy for Complex-Shaped Tumors. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48, 1371-1380.
11. Sarcoma Meta-Analysis Collaboration; Adjuvant Chemotherapy for Localised Resectable Soft-Tissue Sarcoma of Adults: Meta-Analysis of Individual Data. Lancet 1997, 350, 1647-1654.
12. Frustaci, S.; Gherlinzoni, F.; De Paoli, A.; Bonetti, M.; Azzarelli, A.; Comandone, A.; Olmi, P.; Buonadonna, A.; Pignatti, G.; Barbieri, E.; Apice, G.; Zmerly, H.; Serraino, D.; Picci, P. Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial. J. Clin. Oncol. 2001, 19, 1238-1247.
13. Brodowicz, T.; Schwameis, E.; Widder, J.; Amann, G.; Wiltschke, C.; Dominkus, M.; Windhager, R.; Ritschl, P.; Pötter, R.; Kotz, R.; Zielinski, C.C. Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial. Sarcoma 2000, 4, 151-160.
14. Van Glabbeke, M.; van Oosterom, A.T.; Oosterhuis, J.W.; Mouridsen, H.; Crowther, D.; Somers, R.; Verweij, J.; Santoro, A.; Buesa, J.; Tursz, T. Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2185 Patients Treated with Anthracycline-Containing First-Line Regimens-A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J. Clin. Oncol. 1999, 17, 150-157.
15. Billingsley, K.G.; Burt, M.E.; Jara, E.; Ginsberg, R.J.; Woodruff, J.M.; Leung, D.H.; Brennan, M.F. Pulmonary Metastases from Soft Tissue Sarcoma: Analysis of Patterns of Diseases and Postmetastasis Survival. Ann. Surg. 1999, 229, 602-610, discussion 610-612.
16. Sawyer, M.; Bramwell, V. The Treatment of Distant Metastases in Soft Tissue Sarcoma. Semin. Radiat. Oncol. 1999, 9, 389-400.
17. Fata, F.; O'Reilly, E.; Ilson, D.; Pfister, D.; Leffel, D.; Kelsen, D.P. ; Schwartz, G.K.; Casper, E.S. Paclitaxel in the Treatment of Patients with Angiosarcoma of the Scalp or Face. Cancer 1999, 86, 2034-2037.
18. Casper, E.S.; Waltzman, R.J.; Schwartz, G.K.; Sugarman, A.; Pfister, D.; Ilson, D.; Woodruff, J.; Leung, D.; Bertino, J.R. Phase II Trial of Paclitaxel in Patients with Soft-Tissue Sarcoma. Cancer Investig. 1998, 16, 442-446.
19. Edmonson, J.H.; Ryan, L.M.; Blum, R.H.; Brooks, J.S.; Shiraki, M.; Frytak, S.; Parkinson, D.R. Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas. J. Clin. Oncol. 1993, 11, 1269-1275.
20. Delaloge, S.; Yovine, A.; Taamma, A.; Riofrio, M.; Brain, E.; Raymond, E.; Cottu, P.; Goldwasser, F.; Jimeno, J.; Misset, J.L.; Marty, M.; Cvitkovic, E. Ecteinascidin-743: A Marine-Derived Compound in Advanced, Pretreated Sarcoma Patients-Preliminary Evidence of Activity. J. Clin. Oncol. 2001, 19, 1248-1255.
21. Taamma, A.; Misset, J.L.; Riofrio, M.; Guzman, C.; Brain, E.; Lopez Lazaro, L.; Rosing, H.; Jimeno, J.M.; Cvitkovic, E. J. Clin. Oncol. 2001, 19, 1256-1265.
22. Ng, E.H.; Pollock, R.E.; Romsdahl, M.M. Prognostic Implications of Patterns of Failure for Gastrointestinal Leiomyosarcomas. Cancer 1992, 69, 1334-1341.
23. DeMatteo, R.P.; Lewis, J.J.; Leung, D.; Mudan, S.S.; Woodruff, J.M.; Brennan, M.F. Two Hundred Gastrointestinal Stromal Tumors: Recurrence Patterns and Prognostic Factors for Survival. Ann. Surg. 2000, 231, 51-58.
24. Fidler, I.J.; Kerbel, R.S.; Ellis, L.M. Biology of Cancer: Angiogenesis. In Cancer: Principles and Practice of Oncology, 6th Ed.; Devita, V., Jr.; Hellman, S., Rosengerg, S., Eds.; Lippincott, Williams, and Wilkins: Philadelphia, 2001; 137-147.